Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
59.10
+1.29 (2.23%)
At close: Nov 20, 2024, 4:00 PM
59.14
+0.04 (0.07%)
Pre-market: Nov 21, 2024, 7:21 AM EST

Company Description

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.

The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials.

It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services.

In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts.

It provides services through primary and specialty care physicians, hospitals, and ancillary providers.

Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corporation
Centene logo
Country United States
Founded 1984
IPO Date Dec 13, 2001
Industry Healthcare Plans
Sector Healthcare
Employees 67,000
CEO Sarah London

Contact Details

Address:
Centene Plaza, 7700 Forsyth Boulevard
Saint Louis, Missouri 63105
United States
Phone 314 725 4477
Website centene.com

Stock Details

Ticker Symbol CNC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001071739
CUSIP Number 15135B101
ISIN Number US15135B1017
Employer ID 04-1406317
SIC Code 6324

Key Executives

Name Position
David P. Thomas Chief Executive Officer of Markets and Medicaid
Sarah M. London Chief Executive Officer and Director
Kenneth John Fasola President
Andrew Lynn Asher Executive Vice President and Chief Financial Officer
Christopher Andrew Koster Executive Vice President, General Counsel and Secretary
Susan R. Smith Chief Operating Officer
Katie Nicole Casso Senior Vice President, Chief Accounting Officer and Corporate Controller
Brian Phillip LeClaire M.B.A., Ph.D. Chief Information Officer
Jennifer Lynch Gilligan Senior Vice President of Investor Relations
Ashlee Knuckey Chief Risk, Ethics and Compliance Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 8-K Current Report
Nov 12, 2024 8-K Current Report
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 25, 2024 8-K Current Report
Oct 25, 2024 10-Q Quarterly Report
Oct 22, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 11, 2024 8-K Current Report